Table 2 Effect of montelukast on ACT, daily symptom scores, and number of puffs of albuterol/week
From: Asthma in the elderly: a double-blind, placebo-controlled study of the effect of montelukast
Baseline | 4 weeks | 8 weeks | |
|---|---|---|---|
ACT (montelukast) | 22.9 ± 2.1 | 22.8 ± 2.8 | 23 ± 3.2 |
ACT (placebo) | 23.4 ± 2.1 | 22.3 ± 4.4 | |
Daily symptom score (montelukast) | 0.3 ± 0.6 | 0.3 ± 0.5 | 0.3 ± 0.6 |
Daily symptom score (placebo) | 0.3 ± 0.5 | 0.5 ± 0.7 | |
Puffs of albuterol/week (montelukast) | 0.8 ± 1.8 | 1.2 ± 3 | 0.7 ± 1.7 |
Puffs of albuterol/week (placebo) | 0.7 ± 1.5 | 1.5 ± 3.7 |